Related Experiment Video
Updated: Jan 28, 2026
09:23
Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
17.4K
Interatrial shunting for heart failure: current evidence and future perspectives
Leonardo Guimaraes1, Joanne Lindenfeld, Julio Sandoval
1Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Summary
Interatrial shunts decompress heart atria, offering an alternative therapy for heart failure patients refractory to medical treatment. Further trials may establish interatrial shunting as a key approach for chronic heart failure management.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Heart Failure Management
Background:
- Right and left ventricular failure present significant challenges in heart failure management.
- Pulmonary hypertension-right heart failure and left heart failure are often refractory to optimal medical therapy.
- Interatrial shunting is explored as an alternative therapeutic strategy.
Purpose of the Study:
- To evaluate interatrial shunting as a method to decompress the right or left atrium.
- To assess the potential of interatrial shunting to improve symptoms and clinical outcomes in specific heart failure populations.
- To position interatrial shunting as a novel therapeutic approach for refractory heart failure.
Main Methods:
- Creation of an interatrial shunt.
- Application in patients with right ventricular failure (pulmonary hypertension-right heart failure) and left ventricular failure.
- Assessment of symptom improvement and clinical outcomes.
Main Results:
- Interatrial shunting has been utilized as an alternative therapy.
- Observed improvements in symptoms and clinical outcomes in treated patients.
- Ongoing randomized clinical trials are investigating these effects further.
Conclusions:
- Interatrial shunting shows promise as an alternative therapy for refractory heart failure.
- Positive outcomes observed in patients with pulmonary hypertension-right heart failure and left heart failure.
- Interatrial shunting may become an important new approach for chronic heart failure if further trials confirm efficacy.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
872
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
872
01:17Pathophysiology of Heart Failure
3.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
01:27Heart Failure I: Introduction
847
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
847
01:22Heart Failure VI: Adjunct Therapies
314
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
01:22Heart Failure Drugs: Diuretics
948
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
948
01:30Heart Failure V: Medical Management
272
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
272